Tranche 2 Milestone definition

Tranche 2 Milestone means the FDA’s approval of the ARX-04 NDA on or before December 31, 2017.

Tranche 2 Milestone means receipt by the Lender of satisfactory evidence of a successful Ph1 readout of VLS-01 OTF with results justifying a decision to move into Ph2 trials with OTF, as determined by the Lender in its sole discretion.

Tranche 2 Milestone means the satisfaction of each of the following events: (a) no Default or Event of Default shall have occurred and be continuing and (b) Borrower shall have delivered evidence satisfactory to Agent (as determined by Agent in its sole discretion) that Borrower has achieved at least Twelve Million Dollars ($12,000,000) in T6M Net Product Revenue for any financial reporting period ending after the Closing Date and on or prior to December 31, 2023 as set forth in the monthly financial statement delivered in accordance with Section 7.1(a) (and/or quarterly financial statements delivered in accordance with Section 7.1(b) or 7.1(c), if applicable) for such financial reporting period.

Examples of Tranche 2 Milestone in a sentence

• Beginning April 1, 2017 and continuing through December 31, 2017, subject to Borrower’s achievement of Tranche 2 Milestone and approval by Agent’s investment committee, such approval to be granted or withheld in its sole discretion, Borrower may request Tranche 2 Term Loan Advances in an aggregate amount up to $10,000,000 in minimum increments of $2,500,000.

• Except as otherwise provided in Section 4 of this Notice of Grant, you will forfeit the Tranche 2 Performance Option if the Tranche 2 Milestone has not been satisfied as of the four-year anniversary of the Grant Date or to the extent the Tranche 2 Performance Option is unvested as of the date your employment with the Company terminates.

• The rights of the Investor under this Article 2 to appoint Investor Designated Directors to the Board shall terminate in the event that the Company terminates the Joint Development Agreement in accordance with the terms thereof prior to the achievement of the Tranche 2 Milestone (as defined in the Securities Purchase Agreement).

• Subject to the terms and conditions of this Agreement, beginning on the date the Tranche 2 Milestone is satisfied, and continuing through December 15, 2018, Borrower may request Tranche 2 Term Loan Advances in an aggregate amount of $10,000,000 in minimum increments of $1,000,000.

• Subject to and upon the terms and conditions of this Agreement, at any time from the date on which Borrower achieves the Term Loan Tranche 2 Milestone through the Term Loan Xxxxxxx 0 Xxxxxxxxxxxx Xxx Date, Bank agrees to make one (1) or more Term Loan Tranche 2 Advances to Borrower in an aggregate amount not to exceed the Term Loan Tranche 2.

More Definitions of Tranche 2 Milestone

Tranche 2 Milestone means (a) no Event of Default shall have occurred and be continuing; and (b) Borrower’s initiation of a clinical end point trial for at least two of the three following additional indications: (i) aHUS, (ii) c3G for avacopan, and (iii) FSGS for CCX140, in each case subject to verification by Agent in its reasonable discretion.

Tranche 2 Milestone means [*]. Upon determination in good faith by TFG Radiant N-E that it has achieved the Tranche 2 Milestone, TFG Radiant N-E will deliver written notification indicating the date of such achievement to the Chief Executive Officer of Ascent and such documentation reasonably necessary to support the achievement of the Tranche 2 Milestone. Ascent shall have the right to verify achievement of the Tranche 2 Milestone. The parties will negotiate in good faith regarding any dispute regarding the achievement of the Tranche 2 Milestone.

Tranche 2 Milestone means a submission by the Company to the United States Food and Drug Administration (“ FDA ”) of a preclinical study package determined by the Company in good faith to be sufficient to support the filing of an Investigational New Drug application for the Company’s therapy referred to as “OPX-212” (the “ IND ”), so long as such submission occurs on or before (x) February 15, 2016 or (y) any later date agreed to by the Purchasers.

Tranche 2 Milestone means: the Conditions having been satisfied or waived in accordance with this agreement; and [insert description of the Milestone] as evidenced by the receipt by the Investor of a duly completed Milestone Certificate;] [Tranche 3 Completion Date means [insert date] [or] [three (3) Business Days after the satisfaction or waiver of the Tranche 3 Milestone provided the Tranche 3 Milestone is satisfied or waived in accordance with this agreement no later than the Tranche 3 Longstop Date], or such other day agreed between the [Investor[s]/Investor Representative] and the Company;] [Tranche 3 Longstop Date means [insert date];]

Tranche 2 Milestone means Borrower has achieved at least two (2) of the following milestones: (a) achievement of positive data in the ongoing phase 2b study of BIV201 for the treatment of refractory ascites, (b) completion of enrollment of at least ninety percent (90%) of the patients in the ongoing phase 3 study of NE3107 for the treatment of Alzheimer’s Disease, and (c) achievement of positive data from the phase 2 study of NE3107 for the treatment of Xxxxxxxxx’x Disease, in each case as determined by Xxxxxxx in their sole discretion.

Tranche 2 Milestone means that Borrower has: (a) announced positive primary and secondary endpoint results from the BT-001 Pivotal Trial, xxxxxxxxxxxxx.xxx identifier #NCT04886388, sufficient to submit a De Novo Classification Request to the FDA seeking authorization to market BT-001 in the United States for the improvement of glycemic control in patients with type 2 diabetes as the next step in development, without conducting any additional clinical trials; and (b) initiated a pivotal trial evaluating the safety and efficacy of a product candidate in an indication outside of what is used to satisfy clause (a) (i.e., not relating to type 2 diabetes).

Tranche 2 Milestone means a submission by the Company to the United States Food and Drug Administration (“FDA”) of a preclinical study package determined by the Company in good faith to be sufficient to support the filing of an Investigational New Drug application for the Company’s therapy referred to as “OPX-212” (the “IND”), so long as such submission occurs on or before (x) February 15, 2016 or (y) any later date agreed to by the Purchasers.